Patents Assigned to Pulmonx
  • Patent number: 9131942
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: September 15, 2015
    Assignee: PULMONX CORPORATION
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20150231353
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Application
    Filed: May 4, 2015
    Publication date: August 20, 2015
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Srikanth Radhakrishnan, Niyahi Beyhan
  • Patent number: 9107606
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: August 18, 2015
    Assignee: PULMONX CORPORATION
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Patent number: 9050094
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: June 9, 2015
    Assignee: PULMONX CORPORATION
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Sri Radhakrishnan, Niyazi Beyhan
  • Patent number: 8876791
    Abstract: A method and system for increasing the flow resistance of collateral pathways in the lung by employing aspiration to establish an artificial convective flow current between compartments in the lung in order to entrain and deliver a clogging agent preferentially to the collateral pathways. The method may sometimes be performed after lung has been assessed for the presence of collateral pathways.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: November 4, 2014
    Assignee: Pulmonx Corporation
    Inventors: Anthony Wondka, Peter Soltesz, John McCutcheon, Antony J. Fields
  • Publication number: 20140315175
    Abstract: A system for simulating a breathing lung is disclosed. The system comprises a lung model contained within an enclosure, wherein a main bronchus of the lung model is open to ambient air. In one embodiment, the system also comprises a vacuum pump connected to the enclosure, a first normally closed 2-way valve connected to the enclosure, a flow controller connected to both the vacuum pump and the enclosure, and a timer connected to the first normally closed 2-way valve. In alternative embodiments, the system comprises a first pump connected to the enclosure and a second pump connected to the enclosure, wherein the first and second pumps work independently of each other, and wherein the first pump is a vacuum pump, and the second pump is either a peristaltic pump or a piston pump.
    Type: Application
    Filed: January 23, 2013
    Publication date: October 23, 2014
    Applicant: Pulmonx Corporation
    Inventors: Hoang Nguyen, Ryan Olivera, Alex Yang, Sri Radhakrishnan, Steve Wallace, Surag Mantri, Greg Pulido, Ramon Estrada
  • Patent number: 8808194
    Abstract: Methods and systems for targeting, accessing and diagnosing diseased lung compartments are disclosed. The method comprises introducing a diagnostic catheter with an occluding member at its distal end into a lung segment via an assisted ventilation device; inflating the occluding member to isolate the lung segment; and performing a diagnostic procedure with the catheter while the patient is ventilated. The proximal end of the diagnostic catheter is configured to be attached to a console. The method may also comprise introducing the diagnostic catheter into the lung segment; inflating the occluding member to isolate the lung segment; and monitoring blood oxygen saturation. The method may further comprise introducing the diagnostic catheter into the lung segment; determining tidal flow volume in the lung segment; determining total lung capacity of the patient; and determining a flow rank value based on the tidal flow volume of the lung segment and the total lung capacity.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: August 19, 2014
    Assignee: Pulmonx Corporation
    Inventors: Surag Mantri, Srikanth Radhakrishnan
  • Publication number: 20140180155
    Abstract: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.
    Type: Application
    Filed: March 3, 2014
    Publication date: June 26, 2014
    Applicant: Pulmonx Corporation
    Inventor: Lutz Freitag
  • Publication number: 20140142455
    Abstract: Minimally invasive methods, systems and devices are provided for assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding airway of the target compartment. The feeding airway is occluded by the catheter and the opening and closing of a one-way valve coupled with the catheter is observed. If the valve ceases opening and closing over time, this may indicate that significant collateral ventilation into the target compartment is absent. If the valve continues to open and close over time, significant collateral ventilation into the compartment may be present. Based on the collateral ventilation assessment, a treatment plan may be generated.
    Type: Application
    Filed: April 19, 2013
    Publication date: May 22, 2014
    Applicant: Pulmonx Corporation
    Inventors: Lutz Freitag, Nikolai Aljuri
  • Publication number: 20140107396
    Abstract: Devices, systems, and methods for delivering a therapeutic agent to a treatment region in the body are disclosed. By determining a treatment region in the body, reducing the volume of the treatment region to create a target region by using one or more flow control elements and delivering at least one therapeutic agent to the target region, improved treatment may be achieved.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 17, 2014
    Applicant: PulmonX Corporation
    Inventor: Lutz Freitag
  • Publication number: 20140081308
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Application
    Filed: March 6, 2013
    Publication date: March 20, 2014
    Applicant: Pulmonx Corporation
    Inventors: Anthony Wondka, Peter P. Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20140058433
    Abstract: Methods and devices are adapted for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region.
    Type: Application
    Filed: February 14, 2013
    Publication date: February 27, 2014
    Applicant: Pulmonx Corporation
    Inventors: Michael Barrett, Antony J. Fields, Michael J. Hendricksen, Ronald R. Hundertmark, John G. McCutcheon, Alan R. Rapacki, Michael Regan, Steve Wallace
  • Publication number: 20140018605
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: September 20, 2013
    Publication date: January 16, 2014
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20130338524
    Abstract: Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.
    Type: Application
    Filed: November 29, 2012
    Publication date: December 19, 2013
    Applicant: Pulmonx, Inc.
    Inventors: Ajit Nair, Son Gia, Roger Farhnoltz, Nikolai Aljuri
  • Publication number: 20130317293
    Abstract: Devices, methods, and systems for accessing a lung region are provided. The system includes a delivery catheter having a proximal section, a distal section, and a body disposed in-between, wherein the distal region comprises at least one curved section; and a bronchoscope having a proximal section, a distal section, and a body disposed in-between, wherein the bronchoscope is configured to receive the delivery catheter; wherein the delivery catheter is configured to affect a curvature of the distal section of the bronchoscope when the distal section of the delivery catheter is advanced at least partially through the distal end of the bronchoscope.
    Type: Application
    Filed: May 22, 2013
    Publication date: November 28, 2013
    Applicant: PulmonX Corporation
    Inventors: Ryan Olivera, Hoang NGUYEN
  • Patent number: 8568403
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: October 26, 2009
    Date of Patent: October 29, 2013
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20130245484
    Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.
    Type: Application
    Filed: May 10, 2013
    Publication date: September 19, 2013
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney C. Perkins
  • Patent number: 8523782
    Abstract: Minimally invasive methods, systems and devices are provided for assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding airway of the target compartment. The feeding airway is occluded by the catheter and the opening and closing of a one-way valve coupled with the catheter is observed. If the valve ceases opening and closing over time, this may indicate that significant collateral ventilation into the target compartment is absent. If the valve continues to open and close over time, significant collateral ventilation into the compartment may be present. Based on the collateral ventilation assessment, a treatment plan may be generated.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: September 3, 2013
    Assignee: Pulmonx Corporation
    Inventors: Lutz Freitag, Nikolai Aljuri
  • Patent number: 8496006
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: July 30, 2013
    Assignee: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Patent number: 8474460
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: July 2, 2013
    Assignee: Pulmonx Corporation
    Inventors: Michael Barrett, Michael Hendricksen, Alan R. Rapacki, Ronald R. Hundertmark, Jeffrey J. Dolin, Robert M. George, Antony J. Fields, Mark E. Deem, Hanson S. Gifford, III, Ronald French, Douglas Sutton